Good Clinical Practice (GCP)
Full course · Clinical Research Foundations
Free Lesson Preview
Enjoyed this preview?
This lesson is part of a complete GCP track — 2 courses, quizzes, a final exam, and a free verifiable credential. The optional $29 PDF certificate is recognized by 18+ trial sponsors.
Start learning for freeWhy modern medicine relies on systematic evidence-gathering rather than anecdotes, and how clinical research became the foundation for treatments that actually work.
What you will learn5 objectives
By the end of this lesson, you will be able to:
Clinical research is the systematic study of health and illness in human beings. It includes everything from observing patterns in patient populations to testing new treatments to determine whether they are safe and effective. When conducted properly, clinical research generates evidence that can be generalized beyond individual cases to inform care for millions of patients.
For most of human history, medicine was practiced through a combination of tradition, authority, and personal observation. A physician would try a remedy, observe whether the patient improved, and conclude that the remedy worked. If multiple physicians reported similar observations, the remedy became established practice. This is how bloodletting persisted for over two thousand years.
The logic seemed reasonable: Patient has fever. Apply leeches. Fever goes away. Therefore, leeches cure fever.
But this logic has a fatal flaw. Most fevers go away on their own. The body's immune system fights off the infection, and the patient recovers. The leeches had nothing to do with it. In fact, by removing blood from an already weakened patient, bloodletting often made things worse. Yet because patients sometimes recovered after bloodletting (as they would have anyway), physicians continued to believe the treatment was effective.
This same flawed logic still operates today. Someone has a cold, takes echinacea, and feels better in a week. They conclude that echinacea cured their cold. But colds resolve in about a week regardless of treatment. Without comparing people who took echinacea to people who did not, there is no way to know whether the herb made any difference at all.
The Latin phrase "post hoc ergo propter hoc" means "after this, therefore because of this." It describes the logical error of assuming that because one event followed another, the first event caused the second.
Examples in medicine:
This fallacy is the reason we need clinical research: to determine what actually causes improvement, not just what precedes it.
The recognition that medical treatments needed systematic testing came gradually. Let me trace a few pivotal moments that illustrate how our understanding evolved.
In 1747, a Scottish naval surgeon named James Lind faced a crisis. Scurvy was devastating the British navy. On long voyages, sailors developed fatigue, bleeding gums, open sores, and eventually death. More sailors died of scurvy than from combat. Numerous remedies had been proposed: vinegar, cider, seawater, various herbs. But no one knew what actually worked.
Lind did something remarkable for his time. Instead of simply trying a remedy and noting the outcome, he designed a comparative test. He selected twelve sailors with scurvy and divided them into six pairs. Each pair received a different treatment: cider, vinegar, seawater, a paste of garlic and mustard, drops of dilute sulfuric acid, or two oranges and one lemon daily.
The results were dramatic. Within six days, the sailors receiving citrus fruit had recovered enough to nurse the others. The remaining groups showed no improvement.
This was not a perfect experiment by modern standards. Lind did not randomly assign the sailors. He did not use a placebo. The sample size was tiny. But it established a revolutionary principle: when you want to know whether a treatment works, you must compare it systematically to alternatives. You cannot simply give the treatment and observe what happens.
Clinical research is the systematic study of health and disease in humans. It encompasses a wide range of activities, from observing patterns in patient populations to testing whether new treatments are safe and effective. What distinguishes clinical research from ordinary medical practice is its systematic approach and its goal of generating knowledge that extends beyond the individual patient.
When a physician treats a patient and observes the outcome, that is clinical practice. When a researcher designs a study to compare outcomes across many patients, carefully controls for variables that might influence the results, and applies statistical methods to determine whether observed differences are meaningful, that is clinical research.
The fundamental question clinical research addresses is deceptively simple: Does this treatment actually work? But answering that question rigorously requires accounting for everything else that might explain an observed improvement.
Why 'getting better' does not prove a treatment works
Many conditions improve on their own as the body heals. Colds resolve. Sprains heal. Even some cancers occasionally regress without treatment. If we give a treatment and the patient improves, we cannot conclude the treatment caused the improvement unless we know the patient would not have improved anyway.
Believing you are receiving effective treatment can itself produce real physiological changes. Patients given sugar pills for pain often report genuine relief. This is not imagination; measurable changes occur in the brain. Without a comparison group receiving a placebo, we cannot distinguish treatment effects from placebo effects.
Patients typically seek treatment when their symptoms are at their worst. Since symptoms fluctuate naturally, they are statistically likely to improve regardless of treatment. A patient with severe back pain today will probably have less severe pain next week whether or not they receive treatment.
The transformation from anecdote-based to evidence-based medicine is one of the most significant advances in human welfare. Consider a few examples of what changed when we started demanding rigorous evidence.
Hormone replacement therapy: For decades, physicians prescribed hormone replacement therapy (HRT) to postmenopausal women based on observational data suggesting it protected against heart disease. When the Women's Health Initiative conducted a proper randomized trial, it discovered that combined estrogen-plus-progestin therapy actually increased cardiovascular risk. The observational data had been confounded: women who chose HRT were healthier to begin with.
: For most of the twentieth century, ulcers were attributed to stress and treated with antacids, bland diets, and in severe cases, surgery. When researchers proposed that a bacterium called caused most ulcers, the medical establishment was skeptical. Proper clinical trials demonstrated that antibiotics, not antacids, cured ulcers. This discovery transformed treatment and won its discoverers the Nobel Prize.
Evidence-based medicine (EBM) is the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients. It integrates individual clinical expertise with the best available external clinical evidence from systematic research.
The practice of EBM requires:
Not all evidence is created equal. Medical researchers have developed a hierarchy that ranks different types of evidence by their reliability in determining whether treatments work. Understanding this hierarchy is fundamental to understanding why clinical research matters.
Each level represents a different degree of evidence of this hierarchy, explaining what it means and why some forms of evidence are more trustworthy than others.
Expert opinion and anecdotal evidence sit at the bottom. This includes what experienced physicians believe based on their practice, case reports describing individual patients, and testimonials from people who tried a treatment. This evidence is important for generating hypotheses, but it cannot establish whether treatments work. Experts have been wrong throughout medical history, and individual cases cannot account for the confounding factors we discussed earlier.
Case-control studies compare people who have a disease (cases) with people who do not (controls), looking backward to see what exposures or treatments differed between the groups. These studies are useful for identifying risk factors but are prone to recall bias (people with disease may remember exposures differently) and cannot establish causation.
TableComparing Types of Evidence
| Expert Opinion | Draws on clinical experience; can guide initial hypotheses | Subject to bias; experts often disagree; cannot establish causation | Generating questions; guiding practice when better evidence is unavailable |
| Case Reports | Detailed individual data; can identify rare events | Cannot control for confounders; subject to selection and reporting bias | Identifying new conditions or rare adverse events |
| Cohort Studies | Follows patients over time; can assess multiple outcomes | Groups may differ in important ways; expensive and time-consuming | Understanding natural history of disease; long-term outcomes |
| Randomized Trials | Controls for confounders; can establish causation | Expensive; may not reflect real-world conditions; ethical constraints | Determining whether treatments work |
| Meta-analyses | Combines evidence; increases statistical power | Quality depends on underlying studies; publication bias affects results | Summarizing the totality of evidence on a question |
Randomization is the key innovation that makes modern clinical research possible. Let me explain why.
Imagine you want to test whether a new blood pressure medication works. You could simply give it to patients with high blood pressure and see if their blood pressure drops. But as we have discussed, blood pressure fluctuates naturally. Patients who seek treatment often have unusually high readings. They might change their diet or exercise more because they know they are being watched. The placebo effect might lower blood pressure on its own. Without a comparison group, you cannot know whether any improvement was due to the medication.
So you add a comparison group. Some patients receive the new medication; others receive the current standard treatment or a placebo. Now you can compare outcomes. But a new problem emerges: what if the patients in the medication group were healthier to begin with? What if they had less severe hypertension, or were younger, or had fewer other health problems? Any difference in outcomes might be due to these baseline differences, not the medication.
This is where randomization comes in. When you randomly assign patients to groups, the process is like shuffling a deck of cards. On average, all the characteristics that might affect outcomes, age, disease severity, other medications, diet, genetics, factors we have not even thought of, will be distributed equally between the groups. The only systematic difference will be the treatment received.
Randomization accomplishes something remarkable: it controls for every factor that might influence outcomes, including factors we do not know about or cannot measure.
Without randomization, we can only control for factors we think to measure. With randomization, we control for everything, known and unknown, measured and unmeasured. This is why randomized controlled trials are considered the gold standard for determining whether treatments work.
Consider childhood leukemia. In the 1960s, the five-year survival rate for acute lymphoblastic leukemia in children was estimated at less than 10%. According to NCI SEER data, that rate now exceeds 90%.
This transformation happened through clinical research. Researchers systematically tested different chemotherapy combinations, different dosing schedules, different durations of treatment. Each trial built on the knowledge from previous trials. When a new approach showed promise, it became the new standard, and the next trial tested whether it could be improved further. Over decades, this iterative process of hypothesis, testing, refinement, and retesting produced the treatments we have today.
This is what clinical research does. It takes uncertainty and, through systematic inquiry, transforms it into knowledge. It takes hope and, through rigorous testing, determines whether that hope is justified. It takes individual stories and, through aggregation and analysis, reveals the patterns that apply to everyone.
The knowledge generated by clinical research does not stay locked in academic journals. It flows into clinical guidelines, medical school curricula, hospital protocols, and eventually into the exam room where a physician sits with a frightened parent. That parent is desperate for hope. What the physician can offer is something better than hope: evidence. Not certainty, because medicine is never certain. But the most reliable knowledge available about what treatment gives their child the best chance.
Intellectual honesty requires acknowledging that evidence-based medicine has limitations. Clinical research tells us what works on average, but every patient is an individual. A treatment that benefits most patients might harm some. A treatment that shows no average effect might help specific subgroups.
Evidence also takes time to accumulate. When a new disease emerges, as happened with COVID-19, physicians must act before definitive evidence exists. Clinical judgment, informed by relevant prior knowledge and basic biological principles, remains essential when evidence is incomplete.
Furthermore, clinical trials often study narrowly defined populations: younger, healthier, more compliant patients than typical practice encounters. Whether trial results apply to a specific patient requires judgment. A treatment proven effective in 50-year-olds may or may not work in 80-year-olds with multiple other conditions.
Finally, evidence alone cannot make decisions. It informs decisions by clarifying what is likely to happen under different treatment choices. But patients have different values, different priorities, and different tolerances for risk. Evidence-based medicine at its best combines the best available evidence with clinical expertise and patient values to arrive at decisions that serve the individual patient.
Evidence tells us what is likely to happen under different choices. It cannot tell us what we should do, because that depends on what the patient values.
For example, evidence might show that an aggressive cancer treatment offers a 20% chance of cure but causes severe side effects in most patients. A younger patient might choose treatment for that chance at many more years. An elderly patient might prefer comfort and quality of remaining time. Both decisions can be consistent with the same evidence because they reflect different values.
Clinical research generates the evidence. Patients, guided by their physicians, decide what that evidence means for their lives.
If you are beginning a career in clinical research, understanding the foundations we have discussed is essential. You are entering a field that exists because human intuition alone is not enough to determine what heals and what harms. Every procedure you follow, every form you complete, every data point you collect serves the larger purpose of generating evidence that can be trusted.
When you are conducting a clinical trial, you are not merely completing tasks. You are participating in an enterprise that has transformed human health more profoundly than any other endeavor in history. The rigor and integrity you bring to your work directly affects whether the knowledge generated is reliable, and unreliable knowledge can harm patients just as surely as the anecdote-based medicine it replaced.
The mother sitting across from the investigator needs to know whether the treatment for her daughter works. That knowledge exists because researchers conducted trials properly, followed protocols carefully, documented data accurately, and reported results honestly. That is the work you are learning to do.
You now understand why clinical research exists and what distinguishes it from the anecdote-based medicine that preceded it. The next lessons cover the types of clinical research, how clinical trials are designed and conducted, and the regulations and ethical principles that govern research involving human participants.
But remember: everything builds on the foundation we have established here. Clinical research is not merely a set of procedures to follow. It is humanity's best method for discovering what actually works in medicine. When you work in this field, you are continuing a tradition that began with James Lind on a naval vessel in 1747 and has since saved millions of lives.
The next time someone tells you about a treatment that worked for their cousin, or a supplement endorsed by a celebrity, or a remedy that physicians "do not want you to know about," you will understand why that evidence is not enough. And you will understand what kind of evidence is.
Case study · Evidence · beginner · 5
Dr. Morrison's Dilemma
Background
Dr. Robert Morrison is a family physician at Valley Community Health Center. A long-time patient, Mr. Harold Washington, comes in with worsening knee pain from osteoarthritis. Standard treatments including physical therapy, weight loss, and over-the-counter pain relievers have provided only modest relief.
Mr. Washington has read about glucosamine supplements online. "My neighbor Frank swears by them," he says. "He had the same knee problems I do, and after six months on glucosamine, he is playing golf again. Why will you not just prescribe it?"
Dr. Morrison knows the research on glucosamine. Several large, well-designed randomized controlled trials have found that glucosamine is no more effective than placebo for osteoarthritis pain. However, he also knows that many patients report subjective improvement, and the supplements are generally safe.
Consider
A strong response includes
Question 1 of 4. Not yet answered.
Progress saves itself — finish reading and this lesson completes
I have often observed that intelligent, educated people are not immune to this error. We are wired to see patterns and make connections. When event A is followed by event B, our brains want to conclude that A caused B. This instinct served our ancestors well when learning which berries were poisonous. But it misleads us badly when evaluating medical treatments, where the natural course of disease, the placebo effect, and countless other factors can make useless treatments appear to work.
Tragically, it took the Royal Navy nearly 50 years — until 1795 — to mandate citrus rations on its vessels. The evidence was clear, but changing established practice is difficult, especially when tradition and authority support the status quo. This pattern, evidence preceding adoption by decades, has repeated throughout medical history.
When patients and physicians expect a treatment to work, they tend to perceive improvement even when objective measures show none. This is not dishonesty; it is a well-documented feature of human perception. Blinding, where neither patient nor evaluator knows who received active treatment, controls for this bias.
Successes are more likely to be remembered and reported than failures. A practitioner might remember the ten patients who improved with a remedy and forget the twenty who did not. Testimonials suffer from this bias severely: we only hear from people who believe the treatment helped them.
Back surgery: Certain spinal surgeries were performed for decades based on the assumption that they relieved pain by correcting structural problems. When researchers conducted sham-surgery trials, where patients underwent an incision but no actual procedure, they found that sham surgery often worked as well as the real procedure. The surgery's benefit was largely placebo.
These examples illustrate a humbling truth: without rigorous testing, physicians cannot reliably distinguish effective treatments from ineffective ones. Our intuitions mislead us. Our observations are biased. Our reasoning is flawed. Only systematic evidence can cut through the noise.
Cohort studies follow groups of people over time, comparing those who receive a treatment or have an exposure to those who do not. These are more reliable than case-control studies because they observe events as they unfold, but they still cannot account for differences between the groups that might explain different outcomes.
Randomized controlled trials (RCTs) are the workhorse of clinical research. By randomly assigning participants to receive either the treatment under study or a comparison (often a placebo or standard treatment), RCTs ensure that the groups are similar in all ways except the treatment received. When properly conducted, RCTs can establish causation: if the treatment group does better, the treatment likely caused the improvement.
Systematic reviews and meta-analyses sit at the apex. These combine the results of multiple RCTs, increasing statistical power and providing a comprehensive view of all available evidence. A single trial might produce misleading results due to chance; when multiple trials agree, we can be more confident in the conclusions.
If, after randomization, the treatment group has lower blood pressure than the control group, and the difference is large enough that it is unlikely to have occurred by chance, we can conclude that the treatment caused the improvement. Randomization is what allows us to make causal claims rather than merely observational ones.
